These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 10969784

  • 1. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
    Woodworth CD, Gaiotti D, Michael E, Hansen L, Nees M.
    Cancer Res; 2000 Aug 15; 60(16):4397-402. PubMed ID: 10969784
    [Abstract] [Full Text] [Related]

  • 2. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.
    Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, Yuspa SH.
    Carcinogenesis; 2004 Sep 15; 25(9):1771-8. PubMed ID: 15105299
    [Abstract] [Full Text] [Related]

  • 3. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH.
    Oncogene; 1998 May 28; 16(21):2711-21. PubMed ID: 9652737
    [Abstract] [Full Text] [Related]

  • 4. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A.
    Cancer Res; 2003 Nov 15; 63(22):7760-8. PubMed ID: 14633701
    [Abstract] [Full Text] [Related]

  • 5. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dunn AR, Coffey RJ, Yuspa SH.
    Cancer Res; 1995 May 01; 55(9):1883-93. PubMed ID: 7728756
    [Abstract] [Full Text] [Related]

  • 6. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.
    Dlugosz AA, Hansen L, Cheng C, Alexander N, Denning MF, Threadgill DW, Magnuson T, Coffey RJ, Yuspa SH.
    Cancer Res; 1997 Aug 01; 57(15):3180-8. PubMed ID: 9242447
    [Abstract] [Full Text] [Related]

  • 7. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS.
    Oncogene; 2000 Sep 21; 19(40):4611-20. PubMed ID: 11030150
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
    Akerman GS, Tolleson WH, Brown KL, Zyzak LL, Mourateva E, Engin TS, Basaraba A, Coker AL, Creek KE, Pirisi L.
    Cancer Res; 2001 May 01; 61(9):3837-43. PubMed ID: 11325860
    [Abstract] [Full Text] [Related]

  • 9. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D, Welty D, Glick A, Greenhalgh D, Hennings H, Yuspa SH.
    Cancer Res; 1992 Jun 01; 52(11):3145-56. PubMed ID: 1375535
    [Abstract] [Full Text] [Related]

  • 10. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
    Rossiter H, Beissert S, Mayer C, Schön MP, Wienrich BG, Tschachler E, Kupper TS.
    Cancer Res; 2001 May 01; 61(9):3619-26. PubMed ID: 11325830
    [Abstract] [Full Text] [Related]

  • 11. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model.
    Park NH, Gujuluva CN, Baek JH, Cherrick HM, Shin KH, Min BM.
    Oncogene; 1995 Jun 01; 10(11):2145-53. PubMed ID: 7784058
    [Abstract] [Full Text] [Related]

  • 12. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.
    Oncogene; 2000 Aug 31; 19(37):4243-54. PubMed ID: 10980598
    [Abstract] [Full Text] [Related]

  • 13. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC, Azzoli CG, Kadiwar N, Yuspa SH.
    Cancer Res; 1994 Nov 01; 54(21):5584-92. PubMed ID: 7923201
    [Abstract] [Full Text] [Related]

  • 14. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes.
    Wilding J, Vousden KH, Soutter WP, McCrea PD, Del Buono R, Pignatelli M.
    Cancer Res; 1996 Nov 15; 56(22):5285-92. PubMed ID: 8912870
    [Abstract] [Full Text] [Related]

  • 15. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
    DiPaolo JA, Popescu NC, Alvarez L, Woodworth CD.
    Crit Rev Oncog; 1993 Nov 15; 4(4):337-60. PubMed ID: 8394744
    [Abstract] [Full Text] [Related]

  • 16. A model for initiated mouse skin: suppression of papilloma but not carcinoma formation by normal epidermal cells in grafts on athymic nude mice.
    Strickland JE, Ueda M, Hennings H, Yuspa SH.
    Cancer Res; 1992 Mar 15; 52(6):1439-44. PubMed ID: 1540951
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
    Woodworth CD, Chung J, McMullin E, Plowman GD, Simpson S, Iglesias M.
    Cell Growth Differ; 1996 Jun 15; 7(6):811-20. PubMed ID: 8780894
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
    Mathur RS, Mathur SP.
    Gynecol Oncol; 2005 Apr 15; 97(1):206-13. PubMed ID: 15790460
    [Abstract] [Full Text] [Related]

  • 19. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential.
    Liu Z, Ghai J, Ostrow RS, Faras AJ.
    Virology; 1995 Feb 20; 207(1):260-70. PubMed ID: 7871737
    [Abstract] [Full Text] [Related]

  • 20. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
    Kim TW, Porter KL, Foley JF, Maronpot RR, Smart RC.
    Mol Carcinog; 1997 Sep 20; 20(1):115-24. PubMed ID: 9328442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.